Dr.
Anna NOTARO
(Curium Pharma)
13/03/26, 16:30
Glioblastoma represents the most frequent malignant primary brain tumor, with a median overall survival of approximately 15 months and a 5-year survival rate close to 5%. In this setting, positron emission tomography (PET) using O-(2-[18F]fluoroethyl)-L-tyrosine ([18F]FET) has demonstrated significant value for diagnosis, treatment planning, and therapy monitoring.
Despite the strong clinical...
